aid: acesion-pharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/acesion-pharma.png
name: Acesion Pharma
description: >-
  Acesion Pharma is a clinical-stage pharmaceutical company based in Frederiksberg,
  Denmark, developing novel therapies for atrial fibrillation (AF), the most common
  cardiac arrhythmia. The company pioneers small-molecule SK ion channel inhibition
  as a differentiated mechanism to treat AF safely and effectively. Its lead program
  AP31969 entered Phase 2 clinical trials in January 2026, building on earlier work
  on the cardioversion candidate AP30663. Acesion Pharma is backed by venture
  investors including Canaan Partners. As a pharmaceutical R&D company it does not
  currently publish a public developer API, SDK, or API documentation; this profile
  captures its corporate identity and public web properties in the API Evangelist
  network.
url: https://raw.githubusercontent.com/api-evangelist/acesion-pharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-no-api: true
x-no-api-reason: clinical-stage pharmaceutical company; no public developer API surface
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Healthcare
- Life Sciences
- Cardiology
- Atrial Fibrillation
- Drug Development
apis: []
common:
- type: Website
  url: https://acesionpharma.com/
- type: Blog
  url: https://acesionpharma.com/news/
- type: PrivacyPolicy
  url: https://acesionpharma.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/acesion-pharma/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence